Navigation Links
HemoShear Relocates and Expands Operations to Historic Martha Jefferson Property in Charlottesville, Virginia
Date:1/22/2013

CHARLOTTESVILLE, Va., Jan. 22, 2013 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human-relevant systems for drug development and discovery, today announced that it will expand and relocate its operations to downtown Charlottesville, Virginia.  The Company will initially lease 14,800 square feet of the Cardwell Building in the historic former Martha Jefferson Hospital, now owned by Octagon Partners.  The lease allows for expansion to additional floors, as HemoShear's business requires.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO)

HemoShear has grown to more than 30 employees since launching operations in 2009.  The Company continues to expand its customer base, which includes most major biopharmaceutical companies, by deploying its human-relevant systems and scientific expertise to reduce new drug R&D costs and improve success rates of new drug candidates. In 2012, HemoShear received the Rocket Award from the Charlottesville Business Innovation Council for rapid commercialization of a new technology.  

The renovated Cardwell space will allow for continued growth as HemoShear increases the scope of its pharmaceutical customer partnerships and its technology development.  Nicole Hastings , Ph.D., Vice President of Operations, said, "The Cardwell Building has an ideal infrastructure. The new space allows us to design for improved workflow, optimal productivity and quality.  We are also excited to be located near all of the downtown Charlottesville activities and to contribute to the growth of the Charlottesville bioscience community."

Demolition for the new space is underway and HemoShear is actively planning for its move to the Cardwell Building in mid-2013.  Mark Mascotte of MFM Partners, LLC, represented the landlord in the lease transaction.  StellarOne Bank and the Commonwealth of Virginia provided financial assistance to HemoShear. Local contractor Vision Building & Design, LLC will perform the demolition, design and space outfit. 

About HemoShear LLC 
HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases for drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies.  HemoShear's science leads to new medicines and improves human health.  

 


'/>"/>
SOURCE HemoShear LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HemoShear Adds Industry Veterans Mehmood Khan and Fred Brown to Board of Managers
2. HemoShear Unveils In Vitro Steatosis System at Annual Meeting of the Association for the Study of Liver Diseases
3. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
4. Sysmex America Relocates Corporate Headquarters
5. ImmusanT Relocates Offices to State-of-the-Art Innovation Facility
6. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
7. AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center
8. Concentra Expands Medical Services within the Dallas-Fort Worth area
9. AssureRx Health Expands Management Team to Support Increasing Business Growth
10. Cumberland Emerging Technologies Expands Life Sciences Center
11. VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016  Sequent Medical, Inc. gab heute bekannt, ... eine Studie zur Sicherheit und Wirksamkeit des WEB™-Systems ... Behandlung von rupturierten intrakraniellen Aneurysmen begonnen hat. Prof. ... an der Universitätsklinik Bicètre in Paris ... den ersten Patienten aufgenommen. Im Rahmen ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company (NYSE: ... decided the Alimta® (pemetrexed disodium) vitamin regimen patent would not ... UK, France , Italy ... dilute the product only with dextrose solution.  ... the UK Court of Appeal held that Lilly,s patent would ...
(Date:2/12/2016)... Ungarn, February 12, 2016 ... sich auf den ungedeckten medizinischen Bedarf bei ... Ergebnisse seines klinischen Forschungsprogramms bekannt. Das Programm, ... ergab Verbesserungen ihrer respiratorischen Funktionen und anderer ... , ein Medizintechnikunternehmen, das sich auf den ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... ... a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed ... top students from U.S. universities who will draw from Siemens’ deep knowledge ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... the life cycle of pharmaceutical products, garnering increased attention from all stakeholders in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of coconut water beverages ... GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature ... event. The invitation-only gifting suite, held this year at the W Hollywood Hotel, has ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a ... offer real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
(Date:2/12/2016)... ... February 12, 2016 , ... AssureVest Insurance Group, a locally owned insurance firm ... that will raise funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd ... school is in a low-income area and has more than 60 2nd and 3rd ...
Breaking Medicine News(10 mins):